Intrinsic defects in B cell response to seasonal influenza vaccination in elderly humans

Vaccine

Volumn 28, Issue 51, 2010, Pages 8077-8084

  Frasca, Daniela ^a   Diaz, Alain ^a   Romero, Maria ^a   Landin, Ana Marie ^a   Phillips, Mitch ^a   Lechner, Suzanne C ^a   Ryan, John G ^a   Blomberg, Bonnie B ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Aging; B lymphocytes; Immunoglobulin class switch recombination; Influenza vaccination

Indexed keywords

ACTIVATION INDUCED CYTIDINE DEAMINASE; INFLUENZA VACCINE;

ADULT; AGED; ANTIBODY RESPONSE; ARTICLE; B LYMPHOCYTE; CELL CULTURE; CLINICAL ARTICLE; CONTROLLED STUDY; ELDERLY CARE; FEMALE; HEMAGGLUTINATION INHIBITION; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; INFLUENZA VACCINATION; LYMPHOCYTE FUNCTION; MALE; PRIORITY JOURNAL; SEASONAL INFLUENZA; T LYMPHOCYTE;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANTIBODIES, VIRAL; B-LYMPHOCYTES; CYTIDINE DEAMINASE; FEMALE; HEMAGGLUTINATION INHIBITION TESTS; HUMANS; IMMUNOLOGIC MEMORY; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; MIDDLE AGED;

EID: 78649641896     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2010.10.023     Document Type: Article

References (49)

1. Simonsen L., Clarke M.J., Schonberger L.B., Arden N.H., Cox N.J., Fukuda K. Pandemic versus epidemic influenza mortality: a pattern of changing age distribution. J Infect Dis 1998, 178(July (1)):53-60.
2. Boraschi D., Del Giudice G., Dutel C., Ivanoff B., Rappuoli R., Grubeck-Loebenstein B. Ageing and immunity: addressing immune senescence to ensure healthy ageing. Vaccine 2010, 28(May 7):3627-3631.
3. Simonsen L., Taylor R.J., Viboud C., Miller M.A., Jackson L.A. Mortality benefits of influenza vaccination in elderly people: an ongoing controversy. Lancet Infect Dis 2007, 7(10):658-666.
4. Centers for Disease Control Prevention Racial/ethnic disparities in influenza and pneumococcal vaccination levels among persons aged >or =65 years in the United States, 1989-2001. MMWR Morb Mortal Wkly Rep 2003, 52:958-962.
5. Gross P.A., Hermogenes A.W., Sacks H.S., Lau J., Levandowski R.A. The efficacy of influenza vaccine in elderly persons. A meta-analysis and review of the literature. Ann Intern Med 1995, 123(October (17)):518-527.
6. Thompson W.W., Shay D.K., Weintraub E., Brammer L., Bridges C.B., Cox N.J., et al. Influenza-associated hospitalizations in the United States. JAMA 2004, 292(September (11)):1333-1340.
7. Vu T., Farish S., Jenkins M., Kelly H. A meta-analysis of effectiveness of influenza vaccine in persons aged 65 years and over living in the community. Vaccine 2002, 20(March (13-14)):1831-1836.
8. Thompson W.W., Shay D.K., Weintraub E., Brammer L., Cox N., Anderson L.J., et al. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA 2003, 289(January (82)):179-186.
9. Murasko D.M., Bernstein E.D., Gardner E.M., Gross P., Munk G., Dran S., et al. Role of humoral and cell-mediated immunity in protection from influenza disease after immunization of healthy elderly. Exp Gerontol 2002, 37(January-March (2-3)):427-439.
10. Epstein S.L., Misplon J.A., Lawson C.M., Subbarao E.K., Connors M., Murphy B.R. Beta 2-microglobulin-deficient mice can be protected against influenza A infection by vaccination with vaccinia-influenza recombinants expressing hemagglutinin and neuraminidase. J Immunol 1993, 150(June (12)):5484-5493.
11. Saelens X., Vanlandschoot P., Martinet W., Maras M., Neirynck S., Contreras R., et al. Protection of mice against a lethal influenza virus challenge after immunization with yeast-derived secreted influenza virus hemagglutinin. Eur J Biochem 1999, 260(February (1)):166-175.
12. Burlington D.B., Clements M.L., Meiklejohn G., Phelan M., Murphy B.R. Hemagglutinin-specific antibody responses in immunoglobulin G, A, and M isotypes as measured by enzyme-linked immunosorbent assay after primary or secondary infection of humans with influenza A virus. Infect Immun 1983, 41(August (2)):540-545.
13. McMurry J.A., Johansson B.E., De Groot A.S. A call to cellular & humoral arms: enlisting cognate T cell help to develop broad-spectrum vaccines against influenza A. Hum Vaccine 2008, 4(March-April (2)):148-157.
14. Wrammert J., Smith K., Miller J., Langley W.A., Kokko K., Larsen C., et al. Rapid cloning of high-affinity human monoclonal antibodies against influenza virus. Nature 2008, 453(May (7195)):667-671.
15. de Bruijn I.A., Remarque E.J., Jol-van der Zijde C.M., van Tol M.J., Westendorp R.G., Knook D.L. Quality and quantity of the humoral immune response in healthy elderly and young subjects after annually repeated influenza vaccination. J Infect Dis 1999, 179(January (1)):31-36.
16. Goodwin K., Viboud C., Simonsen L. Antibody response to influenza vaccination in the elderly: a quantitative review. Vaccine 2006, 24(February (208)):1159-1169.
17. McElhaney J.E. Influenza vaccination in the elderly: seeking new correlates of protection and improved vaccines. Aging Health 2008, 4(December (16)):603-613.
18. McLaren C., Verbonitz M.W., Daniel S., Grubbs G.E., Ennis F.A. Effect of priming infection on serologic response to whole and subunit influenza virus vaccines in animals. J Infect Dis 1977, 136(December):S706-S711.
19. Ahmed A.E., Nicholson K.G., Nguyen-Van-Tam J.S. Reduction in mortality associated with influenza vaccine during 1989-90 epidemic. Lancet 1995, 346(September (8975)):591-595.
20. Keitel W.A., Cate T.R., Couch R.B. Efficacy of sequential annual vaccination with inactivated influenza virus vaccine. Am J Epidemiol 1988, 127(February (2)):353-364.
21. Goronzy J.J., Fulbright J.W., Crowson C.S., Poland G.A., O'Fallon W.M., Weyand C.M. Value of immunological markers in predicting responsiveness to influenza vaccination in elderly individuals. J Virol 2001, 75(December (24)):12182-12187.
22. Saurwein-Teissl M., Lung T.L., Marx F., Gschosser C., Asch E., Blasko I., et al. Lack of antibody production following immunization in old age: association with CD8(+)CD28(-) T cell clonal expansions and an imbalance in the production of Th1 and Th2 cytokines. J Immunol 2002, 168(June (11)):5893-5899.
23. Frasca D., Van der Put E., Riley R.L., Blomberg B.B. Reduced Ig class switch in aged mice correlates with decreased E47 and activation-induced cytidine deaminase. J Immunol 2004, 172(February (4)):2155-2162.
24. Frasca D., Landin A.M., Lechner S.C., Ryan J.G., Schwartz R., Riley R.L., et al. Aging down-regulates the transcription factor E2A, activation-induced cytidine deaminase, and Ig class switch in human B cells. J Immunol 2008, 180(April (8)):5283-5290.
25. Diagnostic Virology 1994, Yale University Press. 4th ed. G.D. Hsiung, C.K.Y. Fong, M.L. Landry (Eds.).
26. Ito T., Suzuki Y., Mitnaul L., Vines A., Kida H., Kawaoka Y. Receptor specificity of influenza A viruses correlates with the agglutination of erythrocytes from different animal species. Virology 1997, 227(January (2)):493-499.
27. McElhaney J.E., Meneilly G.S., Lechelt K.E., Beattie B.L., Bleackley R.C. Antibody response to whole-virus and split-virus influenza vaccines in successful ageing. Vaccine 1993, 11(10):1055-1060.
28. Powers D.C. Summary of a clinical trial with liposome-adjuvanated influenza A virus vaccine in elderly adults. Mech Ageing Dev 1997, 93(February (1-3)):179-188.
29. Muramatsu M., Nagaoka H., Shinkura R., Begum N.A., Honjo T. Discovery of activation-induced cytidine deaminase, the engraver of antibody memory. Adv Immunol 2007, 94:1-36.
30. Nussenzweig M.C., Alt F.W. Antibody diversity: one enzyme to rule them all. Nat Med 2004, 10(December (12)):1304-1305.
31. Okazaki I.M., Kinoshita K., Muramatsu M., Yoshikawa K., Honjo T. The AID enzyme induces class switch recombination in fibroblasts. Nature 2002, 416(March (6878)):340-345.
32. Teng G., Papavasiliou F.N. Immunoglobulin somatic hypermutation. Annu Rev Genet 2007, 41:107-120.
33. Sambhara S., McElhaney J.E. Immunosenescence and influenza vaccine efficacy. Curr Top Microbiol Immunol 2009, 333:413-429.
34. Kovaiou R.D., Herndler-Brandstetter D., Grubeck-Loebenstein B. Age-related changes in immunity: implications for vaccination in the elderly. Expert Rev Mol Med 2007, 9(3):1-17.
35. Pawelec G., Barnett Y., Forsey R., Frasca D., Globerson A., McLeod J., et al. T cells and aging January 2002 update. Front Biosci 2002, 7(May):d1056-d1183.
36. Vallejo A.N. CD28 extinction in human T cells: altered functions and the program of T-cell senescence. Immunol Rev 2005, 205(June):158-169.
37. Pawelec G., Derhovanessian E., Larbi A., Strindhall J., Wikby A. Cytomegalovirus and human immunosenescence. Rev Med Virol 2009, 19(January (1)):47-56.
38. Olsson J., Wikby A., Johansson B., Lofgren S., Nilsson B.O., Ferguson F.G. Age-related change in peripheral blood T-lymphocyte subpopulations and cytomegalovirus infection in the very old: the Swedish longitudinal OCTO immune study. Mech Ageing Dev 2000, 121(December (1-3)):187-201.
39. Tangye S.G., Tarlinton D.M. Memory B cells: effectors of long-lived immune responses. Eur J Immunol 2009, 39(August (8)):2065-2075.
40. Weill J.C., Weller S., Reynaud C.A. Human marginal zone B cells. Annu Rev Immunol 2009, 27:267-285.
41. Manz R.A., Radbruch A. Plasma cells for a lifetime?. Eur J Immunol 2002, 32(April (4)):923-927.
42. Bernasconi N.L., Traggiai E., Lanzavecchia A. Maintenance of serological memory by polyclonal activation of human memory B cells. Science 2002, 298(December (5601)):2199-2202.
43. Di Genova G., Roddick J., McNicholl F., Stevenson F.K. Vaccination of human subjects expands both specific and bystander memory T cells but antibody production remains vaccine specific. Blood 2006, 107(April (7)):2806-2813.
44. Amanna I.J., Carlson N.E., Slifka M.K. Duration of humoral immunity to common viral and vaccine antigens. N Engl J Med 2007, 357(November (19)):1903-1915.
45. Sasaki S., He X.S., Holmes T.H., Dekker C.L., Kemble G.W., Arvin A.M., et al. Influence of prior influenza vaccination on antibody and B-cell responses. PLoS One 2008, 3(8):e2975.
46. McMichael A.J., Gotch F.M., Noble G.R., Beare P.A. Cytotoxic T-cell immunity to influenza. N Engl J Med 1983, 309(July (1)):13-17.
47. McElhaney J.E., Ewen C., Zhou X., Kane K.P., Xie D., Hager W.D., et al. Granzyme B: correlates with protection and enhanced CTL response to influenza vaccination in older adults. Vaccine 2009, 27(April (18)):2418-2425.
48. Shahid Z., Kleppinger A., Gentleman B., Falsey A.R., McElhaney J.E. Clinical and immunologic predictors of influenza illness among vaccinated older adults. Vaccine 2010, 28(Aug 31):6145-6151.
49. Frasca D, Diaz A, Romero M, Landin AM, Blomberg BB. Age effects on B cells and humoral immunity in humans. Ageing Res Rev 2010 (Aug 20).